1ST Source Bank’s AbbVie ABBV Stock Holding History

1ST Source Bank’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.63M	Sell	26,366 -224	-0.8%	-$48.2K	0.3%	46
2026 Q1	$5.78M	Sell	26,590 -187	-0.7%	-$41.5K	0.3%	50
2025 Q4	$6.12M	Buy	26,777 +106	+0.4%	+$24.1K	0.32%	48
2025 Q3	$6.18M	Sell	26,671 -269	-1%	-$54.8K	0.33%	48
2025 Q2	$5M	Sell	26,940 -833	-3%	-$155K	0.28%	52
2025 Q1	$5.82M	Sell	27,773 -497	-2%	-$96.6K	0.34%	46
2024 Q4	$5.02M	Sell	28,270 -219	-0.8%	-$40.3K	0.29%	52
2024 Q3	$5.63M	Sell	28,489 -328	-1%	-$61.2K	0.32%	46
2024 Q2	$4.94M	Sell	28,817 -559	-2%	-$92.6K	0.29%	52
2024 Q1	$5.35M	Sell	29,376 -341	-1%	-$58.8K	0.31%	49
2023 Q4	$4.61M	Sell	29,717 -326	-1%	-$47.5K	0.28%	55
2023 Q3	$4.48M	Buy	30,043 +60	+0.2%	+$8.81K	0.3%	51
2023 Q2	$4.04M	Sell	29,983 -90	-0.3%	-$13.2K	0.26%	58
2023 Q1	$4.79M	Sell	30,073 -212	-0.7%	-$32.4K	0.32%	47
2022 Q4	$4.89M	Buy	30,285 +211	+0.7%	+$32.4K	0.32%	47
2022 Q3	$4.04M	Buy	30,074 +305	+1%	+$43.8K	0.29%	50
2022 Q2	$4.56M	Sell	29,769 -343	-1%	-$52.4K	0.32%	43
2022 Q1	$4.88M	Buy	30,112 +541	+2%	+$78.6K	0.3%	46
2021 Q4	$4M	Buy	29,571 +5,374	+22%	+$635K	0.23%	62
2021 Q3	$2.61M	Buy	24,197 +1,152	+5%	+$132K	0.16%	75
2021 Q2	$2.6M	Buy	23,045 +644	+3%	+$72.5K	0.16%	76
2021 Q1	$2.42M	Sell	22,401 -1,510	-6%	-$162K	0.16%	77
2020 Q4	$2.56M	Buy	23,911 +2,157	+10%	+$207K	0.19%	72
2020 Q3	$1.91M	Sell	21,754 -3,076	-12%	-$290K	0.16%	85
2020 Q2	$2.44M	Buy	24,830 +3,813	+18%	+$336K	0.21%	71
2020 Q1	$1.6M	Buy	21,017 +1,580	+8%	+$135K	0.16%	83
2019 Q4	$1.72M	Buy	19,437 +621	+3%	+$51.6K	0.13%	88
2019 Q3	$1.43M	Sell	18,816 -2,155	-10%	-$148K	0.12%	94
2019 Q2	$1.52M	Sell	20,971 -1,158	-5%	-$91K	0.12%	90
2019 Q1	$1.78M	Buy	22,129 +473	+2%	+$38.7K	0.15%	82
2018 Q4	$2M	Buy	21,656 +106	+0.5%	+$9.32K	0.19%	73
2018 Q3	$2.04M	Sell	21,550 -145	-0.7%	-$13.8K	0.16%	77
2018 Q2	$2.01M	Sell	21,695 -1,935	-8%	-$189K	0.16%	79
2018 Q1	$2.24M	Buy	23,630 +229	+1%	+$25.2K	0.19%	73
2017 Q4	$2.26M	Sell	23,401 -412	-2%	-$38.8K	0.19%	71
2017 Q3	$2.12M	Sell	23,813 -347	-1%	-$26.4K	0.18%	73
2017 Q2	$1.75M	Sell	24,160 -96	-0.4%	-$6.45K	0.15%	84
2017 Q1	$1.58M	Sell	24,256 -118	-0.5%	-$7.42K	0.14%	90
2016 Q4	$1.53M	Sell	24,374 -322	-1%	-$19.7K	0.14%	82
2016 Q3	$1.56M	Buy	24,696 +2,700	+12%	+$175K	0.16%	83
2016 Q2	$1.36M	Buy	21,996 +951	+5%	+$57.9K	0.15%	89
2016 Q1	$1.2M	Sell	21,045 -528	-2%	-$29.4K	0.13%	93
2015 Q4	$1.28M	Sell	21,573 -1,805	-8%	-$104K	0.15%	86
2015 Q3	$1.27M	Buy	23,378 +3,247	+16%	+$211K	0.15%	91
2015 Q2	$1.35M	Buy	20,131 +283	+1%	+$18.5K	0.15%	90
2015 Q1	$1.16M	Sell	19,848 -126	-0.6%	-$7.61K	0.14%	100
2014 Q4	$1.31M	Buy	19,974 +800	+4%	+$50.4K	0.16%	91
2014 Q3	$1.11M	Sell	19,174 -969	-5%	-$53.8K	0.15%	98
2014 Q2	$1.14M	Sell	20,143 -365	-2%	-$19.1K	0.15%	98
2014 Q1	$1.05M	Sell	20,508 -100	-0.5%	-$5.05K	0.14%	102
2013 Q4	$1.09M	Sell	20,608 -56	-0.3%	-$2.75K	0.15%	102
2013 Q3	$924K	Sell	20,664 -194	-0.9%	-$8.6K	0.14%	109
2013 Q2	$862K	Buy	+20,858	New	+$912K	0.15%	99

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

1ST Source Bank's ABBV Position: Q2 2026 in Review

1ST Source Bank reduced its AbbVie (ABBV) stake by 0.84% in Q2 2026, selling an estimated $48.2K and leaving 26,366 shares worth $6.63M. The position accounts for 0.3% of the portfolio, ranked #46.

1ST Source Bank first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

1ST Source Bank held 26,366 shares of AbbVie worth $6.63M as of Q2 2026.
1ST Source Bank sold 224 AbbVie shares in Q2 2026, an estimated $48.2K.
AbbVie made up 0.3% of 1ST Source Bank's portfolio in Q2 2026, its #46 holding.
1ST Source Bank first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on 1ST Source Bank's 13F filing for Q2 2026, filed 6 Aug 2026.